Fact CheckerSign in

NCT06938477Completed

Thera-Trainer Exercise Effects on Motor and Cognitive Outcomes in Stroke: RCT

EFFECTS OF THERA-TRAINER BASED EXERCISES ON MOTOR AND COGNITIVE PERFORMANCE AMONG HEMİPARATİC STROKE PATIENTS. A RANDOMİSED CONTROL TRİAL

Source: ClinicalTrials.gov · Last updated 18 Jun 2025

Brief summary (registry, in English)

Technology-supported training supports the rehabilitation process by providing high-intensity, repetitive, and task-specific treatment, contributes to the recovery process, and facilitates the restoration of arm function (Bertani et al., 2017). Technology-supported rehabilitation studies for the upper extremity are performed using different devices. THERA-Trainer Tigo is used for the mobilization of individuals with limited mobility after trauma or due to any reason; it is suitable for passive movement training and active movement. Treatment with active-passive exercise devices facilitates rehabilitation with natural and rhythmic movements. It allows almost all patients, from wheelchair users to walkers, to actively participate in bicycle training during the rehabilitation process (Pazo et al., 2017). There are very few studies in the literature examining the relationship between cognitive and motor performance functions of THERA-Trainer-based exercises, and the aim of this study is to provide a preliminary idea in terms of progression to clinicians during the evaluation phase and treatment, to contribute to treatment, and to academic researchers.

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
14 Apr 2025
Start date
19 May 2024
Primary completion date
15 Mar 2025
Lead sponsor
Tarsus University
Diseases
Stroke
NCT number
NCT06938477

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 19 May 2024 to the primary completion date, 15 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who have undergone any botulinum toxin application or surgery in the last 6 months

Other illness

  • Agnosia or visual impairment,

Other

  • Montreal Cognitive Assessment (MOCA) score of less than 21,
  • Upper extremity spasticy of over 3 according to MAS,
  • Patients with subluxation and fracture risk in the shoulder,
  • Limited joint movement in the hemiplegic side upper extremity,

Who the study is looking for

  • Having had an ischemic or hemorrhagic stroke for the first time
  • Those with a Montreal Cognitive Assessment (MOCA) score above 21,
  • Individuals with a functional level below 4 according to the modified Rankin scale (MRS),
  • Individuals with upper extremity spasm below 3 according to the modified Ashword scale (MAS)

Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fatma KÜBRA Çekok
Coordinator of this site? Confirm its status
TarsusTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.